Detalhe da pesquisa
1.
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
Nat Immunol
; 25(2): 282-293, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38172257
2.
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
Nat Immunol
; 25(4): 717, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38347083
3.
The Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis cohort population structure and disease etiology.
medRxiv
; 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38712288